论文标题
在存在信号依赖性主行干扰的情况下,使用SINR标准的SINR标准优化了FDA雷达的波形优化
Waveform Optimization with SINR Criteria for FDA Radar in the Presence of Signal-Dependent Mainlobe Interference
论文作者
论文摘要
在本文中,我们着重于在存在信号依赖性主体行干扰的情况下提高输出信号与互助 - 噪声比率(SINR)的频率多样阵列(FDA)的发射波形的设计。由于基于经典的多载波匹配的基于过滤的FDA接收器无法有效利用FDA的波形多样性,因此开发了基于多渠道混合和低通滤波的新型FDA接收器框架,以保持接收器的传输波形的分离,同时保留FDA范围范围范围范围范围范围范围,以保留FDA范围范围可连接的自由度。此外,引入了范围角度最小差异无失真的响应束缚技术,以使接收器滤波器的权重抑制可能的信号依赖性主路线干扰。最初将最初的FDA传输波形设计问题作为优化问题提出,该优化问题由非凸目标函数和多个非凸约限制组成。为了有效地,我们介绍了两种算法,一种基于信号弛豫技术,另一个基于主要化最小化技术。使用数值模拟说明了所提出的多渠道低通滤波接收器和优化的发射波形的优选性能,这表明所得的FDA系统不仅能够有效地抑制大主体漏洞的干扰,而且还可以在没有波形优化的FDA系统的情况下有效地抑制Minr估计值。
In this paper, we focus on the design of the transmit waveforms of a frequency diverse array (FDA) in order to improve the output signal-to-interference-plus-noise ratio (SINR) in the presence of signal-dependent mainlobe interference. Since the classical multi-carrier matched filtering-based FDA receiver cannot effectively utilize the waveform diversity of FDA, a novel FDA receiver framework based on multi-channel mixing and low-pass filtering is developed to keep the separation of the transmit waveform at the receiver side, while preserving the FDA range-controllable degrees of freedom. Furthermore, a range-angle minimum variance distortionless response beamforming technique is introduced to synthesize receiver filter weights with the ability to suppress a possible signal-dependent mainlobe interference. The resulting FDA transmit waveform design problem is initially formulated as an optimization problem consisting of a non-convex objective function and multiple non-convex constraints. To efficiently slove this, we introduce two algorithms, one based on a signal relaxation technique, and the other based on the majorization minimization technique. The preferable performance of the proposed multi-channel low-pass filtering receiver and the optimized transmit waveforms is illustrated using numerical simulations, indicating that the resulting FDA system is not only able to effectively suppress mainlobe interference, but also to yield estimates with a higher SINR than the FDA system without waveform optimization.